AB

Active Director Director DIN 09447223
DIN 09447223 First appointment Dec 2021 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Anju Bala

Data last updated:

Anju Bala is a Director at Medvilla Healthcare Private Limited (since 2021). The company operates in Food And Beverages.

DIN 09447223
Primary Designation Director
Industry Food And Beverages
First Appointment 07 Dec 2021
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medvilla Healthcare Private Limited U24304JK2020PTC011825
Director07 Dec 20212020Active

Board colleagues of Anju Bala

Directorship timeline

Open interactive timeline →
Medvilla Healthcare Private Limited
Premium access

Shareholding and investment profile for Anju Bala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anju Bala

Anju Bala currently holds 1 directorship: Medvilla Healthcare Private Limited (Director, since 07 Dec 2021).

Anju Bala was first appointed on 07 Dec 2021 as Director at Medvilla Healthcare Private Limited.

The current boards of Anju Bala's companies include Anmol Kohli (Medvilla Healthcare Private Limited), Shubam Sharma (Medvilla Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available